Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis

Indian Pediatrics

Volumn 44, Issue 9, 2007, Pages 649-656

  Sankar, Jhuma ^a   Singhi, P ^a   Bansal, A ^a   Ray, P ^a   Singhi, Sunit ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Acute bacterial meningitis; Dexamethasone; Glycerol; Hearing loss; Neurological sequelae

Indexed keywords

CARBOXYMETHYLCELLULOSE; CEFTRIAXONE; DEXAMETHASONE; GLYCEROL; SODIUM CHLORIDE;

ANALYTIC METHOD; ARTICLE; BACTERIAL MENINGITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; HEARING DISORDER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFLUENZA; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PEDIATRICS; PRESCHOOL CHILD; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA; TEACHING HOSPITAL; TERTIARY HEALTH CARE;

ACUTE DISEASE; ADMINISTRATION, ORAL; CHILD; CHILD, PRESCHOOL; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLYCEROL; HEARING LOSS; HEARING TESTS; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALE; MENINGITIS, BACTERIAL; NERVOUS SYSTEM DISEASES; NEUROPSYCHOLOGICAL TESTS; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34948903280     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis. in children: a meta-analysis. Pediatr Infect Dis J 1993; 12: 389-394.
2. Koomen I, Grobbee DE, Roord JJ, Donders R, Jennekens-Schinkel A, van Furth AM. Hearing loss at school age in survivors of bacterial meningitis: Assessment, incidence, and prediction. Pediatrics 2003; 112: 1049-1053.
3. Richardson MP, Reid A, Tarlow MJ, Rudd PT. Hearing loss during bacterial meningitis. Arch Dis Child 1997; 76; 134-138.
4. Grimwood K, Anderson P, Anderson V, Tan L, Nolan T. Twelve year outcomes following bacterial meningitis: further evidence for persisting effects. Arch Dis Child 2000; 83: 111-116.
5. Singhi P, Bansal A, Geeta P, Singhi S. Predictors of long term neurological outcome in bacterial meningitis. Indian J Pediatr 2007; 74: 369-374.
6. George CN, Letha S, Bai SS. A clinical study of chronic morbidity in children following pyogenic meningitis. Indian Pediatr 2002; 39: 663-667.
7. Wandi F, Kiagi G, Duke T. Long-term outcome for children with bacterial meningitis in rural Papua New Guinea. J Trop Pediatr 2005; 51: 51-53.
8. Odio CM, Faingezicht I, Paris M, Nassar M, Baltodano A, Rogers J, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 1991; 324: 1525-1531.
9. Lebel MH, Freij BJ, Syrogiannopoulos GA, Chrane DF, Hoyt MJ, Stewart SM, et al. Dexamethasone therapy for bacterial meningitis. Results of two double blind, placebo-controlled trials. N Engl J Med 1988; 319: 964-971.
10. Schaad UB, Lips U, Gnehm HE, Blumberg A, Heinzer I, Wedgwood J. Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. Lancet 1993; 342: 457-461.
11. Molyneux EM, Walsh AL, Forsyth H, Tembo M, Mwenechanya J, Kayira K, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomized control trial. Lancet 2002; 360: 211-218.
12. Qazi SA, Khan MA, Mughal N, Ahmad M, Joomro B, Sakata Y, et al. Dexamethasone and bacterial meningitis in Pakistan. Arch Dis Child. 1996; 75: 482-488.
13. Arditi M, Mason EO Jr, Bradley JS, Tan TQ, Barson WJ, Schutze GE et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998; 102: 1087-1097.
14. WHO. Antimicrobial and support therapy for bacterial meningitis in children. Report of the meeting of 18-20 June 1997, Geneva, WHO/CHD/98.6, WHO/EMC/BAC/98.2.
15. Kilpi T, Peltola H, Jauhiainen T, Kallio MJ. Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatr Infect Dis J 1995; 14: 270-278.
16. Oostenbrink R, Maas M, Moons KG, Moll HA. Sequelae after bacterial meningitis in childhood. Scand J Infect Dis 2002; 34: 379-382.
17. Casella EB, Cypel S, Osmo AA, Okay Y, Lefevre BH, Lichtig I, et al. Sequelae from meningococcal meningitis in children: a critical analysis of dexamethasone therapy. Arq Neuropsiquiatr 2004; 62: 421-428.
18. Oostenbrink R, Moons KG, Derksen-Lubsen G, Grobbee DE, Moll HA. Early prediction of neurological sequelae or death after bacterial meningitis Acta Paediatr 2002; 91: 391-398.
19. Peltola H. Burden of meningitis and other severe bacterial infections of children in Africa: Implications for prevention. Clin Infect Dis 2001; 32: 64-75.
20. Wald SL, McLaurin RL. Oral glycerol for the treatment of traumatic intracranial hypertension. J Neurosurg 1982; 56: 323-331.
21. Treib J, Becker SC, Grauer M, Haass A. Transcranial doppler monitoring of intracranial pressure therapy with mannitol, sorbitol and glycerol in patients with acute stroke. Eur Neurol 1998; 40: 212-219.
22. Sakamaki M, Igarashi H, Nishiyama Y, Hagiwara H, Ando J, Chishiki T, et al. Effect of glycerol on ischemic cerebral edema assessed by magnetic resonance imaging. J Neurol Sci 2003; 209: 69-74.
23. Rottenberg DA, Hurwitz BJ, Posner JB. The effect of oral glycerol on intra ventricular pressure in man. Neurology 1977; 27: 600-608.
24. Macaluso A, Pivetta S, Maggi RS, Tamburlini G, Cattaneo A. Dexamethasone adjunctive therapy for bacterial meningitis in children: a retrospective study in Brazil. Ann Trop Paediatr 1996; 16: 193-198.
25. de Gans J, van de Beek D; European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002; 347: 1549-1556.
26. Van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids in acute bacterial meningitis. Cochrane Database Syst Rev. 2003; (3): CD004405.
27. El Bashir H, Laundy M, Booy R. Diagnosis and treatment of bacterial meningitis. Arch Dis Child 2003; 88: 615-620.
28. Kanra GY, Ozen H, Secmeer G, Ceyhan M, Ecevit Z, Belgin E. Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J 1995; 14: 490-494.
29. Cherian B, Singh T, Chacko B, Abraham A. Sensorineural hearing loss following acute bacterial meningitis in non-neonates. Indian J Pediatr 2002; 69: 951-955.